Literature DB >> 29502200

Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.

Esteban Luna1, Samantha C Decker1, Dawn M Riddle1, Anna Caputo1, Bin Zhang1, Tracy Cole2, Carrie Caswell3, Sharon X Xie3, Virginia M Y Lee1, Kelvin C Luk4.   

Abstract

The accumulation of misfolded α-synuclein (aSyn) and neuron loss define several neurodegenerative disorders including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). However, the precise relationship between pathology and neurotoxicity and why these processes disproportionately affect certain neuron subpopulations are poorly understood. We show here that Math2-expressing neurons in the hippocampal Cornu ammonis (CA), a region significantly affected by aSyn pathology in advanced PD and DLB, are highly susceptible to pathological seeding with pre-formed fibrils (PFFs), in contrast to dentate gyrus neurons, which are relatively spared. Math2+ neurons also exhibited more rapid and severe cell loss in both in vitro and in vivo models of synucleinopathy. Toxicity resulting from PFF exposure was dependent on endogenous aSyn and could be attenuated by N-acetyl-cysteine through a glutathione-dependent process. Moreover, aSyn expression levels strongly correlate with relative vulnerability among hippocampal neuron subtypes of which Math2+ neurons contained the highest amount. Consistent with this, antisense oligonucleotide (ASO)-mediated knockdown of aSyn reduced the neuronal pathology in a time-dependent manner. However, significant neuroprotection was observed only with early ASO intervention and a substantial reduction of aSyn pathology, indicating toxicity occurs after a critical threshold of pathological burden is exceeded in vulnerable neurons. Together, our findings reveal considerable heterogeneity in endogenous aSyn levels among hippocampal neurons and suggest that this may contribute to the selective vulnerability observed in the context of synucleinopathies.

Entities:  

Keywords:  Differential vulnerability; Lewy pathology; Pre-formed fibrils; Primary hippocampal neurons; α-Synuclein

Mesh:

Substances:

Year:  2018        PMID: 29502200      PMCID: PMC5955788          DOI: 10.1007/s00401-018-1829-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  83 in total

1.  Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.

Authors:  Jon B Toledo; Pallavi Gopal; Kevin Raible; David J Irwin; Johannes Brettschneider; Samantha Sedor; Kayla Waits; Susana Boluda; Murray Grossman; Vivianna M Van Deerlin; Edward B Lee; Steven E Arnold; John E Duda; Howard Hurtig; Virginia M-Y Lee; Charles H Adler; Thomas G Beach; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2015-12-31       Impact factor: 17.088

2.  Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.

Authors:  Jeffrey H Kordower; C Warren Olanow; Hemraj B Dodiya; Yaping Chu; Thomas G Beach; Charles H Adler; Glenda M Halliday; Raymond T Bartus
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

Review 3.  Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nature       Date:  2013-09-05       Impact factor: 49.962

Review 4.  Selective neuronal vulnerability in Parkinson disease.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

5.  Lewy bodies in the lateral hypothalamus: do they imply neuronal loss?

Authors:  H P Kremer; G T Bots
Journal:  Mov Disord       Date:  1993-07       Impact factor: 10.338

Review 6.  The neuropathology of genetic Parkinson's disease.

Authors:  Markos Poulopoulos; Oren A Levy; Roy N Alcalay
Journal:  Mov Disord       Date:  2012-03-26       Impact factor: 10.338

7.  Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology.

Authors:  David H Adamowicz; Subhojit Roy; David P Salmon; Douglas R Galasko; Lawrence A Hansen; Eliezer Masliah; Fred H Gage
Journal:  J Neurosci       Date:  2016-12-30       Impact factor: 6.167

8.  Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity.

Authors:  Kelvin C Luk; Dustin J Covell; Victoria M Kehm; Bin Zhang; Insung Y Song; Matthew D Byrne; Rose M Pitkin; Samantha C Decker; John Q Trojanowski; Virginia M-Y Lee
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

9.  Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.

Authors:  Changyoun Kim; Dong-Hwan Ho; Ji-Eun Suk; Sungyong You; Sarah Michael; Junghee Kang; Sung Joong Lee; Eliezer Masliah; Daehee Hwang; He-Jin Lee; Seung-Jae Lee
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS.

Authors:  Michael E Østergaard; Amber L Southwell; Holly Kordasiewicz; Andrew T Watt; Niels H Skotte; Crystal N Doty; Kuljeet Vaid; Erika B Villanueva; Eric E Swayze; C Frank Bennett; Michael R Hayden; Punit P Seth
Journal:  Nucleic Acids Res       Date:  2013-08-19       Impact factor: 16.971

View more
  47 in total

Review 1.  α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.

Authors:  Michael X Henderson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neurosci Lett       Date:  2019-06-03       Impact factor: 3.046

Review 2.  Transmission of α-synuclein seeds in neurodegenerative disease: recent developments.

Authors:  Richard J Karpowicz; John Q Trojanowski; Virginia M-Y Lee
Journal:  Lab Invest       Date:  2019-02-13       Impact factor: 5.662

3.  Noninvasive delivery of an α-synuclein gene silencing vector with magnetic resonance-guided focused ultrasound.

Authors:  Kristiana Xhima; Fadl Nabbouh; Kullervo Hynynen; Isabelle Aubert; Anurag Tandon
Journal:  Mov Disord       Date:  2018-09-28       Impact factor: 10.338

Review 4.  Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?

Authors:  Yvette C Wong; Kelvin Luk; Kerry Purtell; Samuel Burke Nanni; A Jon Stoessl; Louis-Eric Trudeau; Zhenyu Yue; Dimitri Krainc; Wolfgang Oertel; Jose A Obeso; Laura A Volpicelli-Daley
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

5.  α-Synuclein Propagation Mouse Models of Parkinson's Disease.

Authors:  Norihito Uemura; Jun Ueda; Shinya Okuda; Masanori Sawamura; Ryosuke Takahashi
Journal:  Methods Mol Biol       Date:  2021

6.  Autophagy activation promotes clearance of α-synuclein inclusions in fibril-seeded human neural cells.

Authors:  Jianqun Gao; Gayathri Perera; Megha Bhadbhade; Glenda M Halliday; Nicolas Dzamko
Journal:  J Biol Chem       Date:  2019-08-02       Impact factor: 5.157

7.  Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo.

Authors:  Qihui Wu; Muhammad A Shaikh; Emily S Meymand; Bin Zhang; Kelvin C Luk; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol       Date:  2020-10-06       Impact factor: 17.088

Review 8.  Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nat Neurosci       Date:  2018-09-26       Impact factor: 24.884

9.  Amyloid-Beta (Aβ) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with Aβ Pathology.

Authors:  Fares Bassil; Hannah J Brown; Shankar Pattabhiraman; Joe E Iwasyk; Chantal M Maghames; Emily S Meymand; Timothy O Cox; Dawn M Riddle; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neuron       Date:  2019-11-20       Impact factor: 17.173

Review 10.  Cell-to-Cell Transmission of Tau and α-Synuclein.

Authors:  Norihito Uemura; Maiko T Uemura; Kelvin C Luk; Virginia M-Y Lee; John Q Trojanowski
Journal:  Trends Mol Med       Date:  2020-05-01       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.